140 related articles for article (PubMed ID: 38526825)
1. Application of the U.S. Food and Drug Administration's Sentinel Routine Querying Tools to the Taiwan Sentinel Data Model-formatted National Health Insurance Research Database.
Lin FJ; Huang LY; Wang CC; Toh S
J Food Drug Anal; 2023 Dec; 31(4):772-781. PubMed ID: 38526825
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the US Food and Drug Administration Sentinel Analysis Tools Using a Comparator with a Different Indication: Comparing the Rates of Gastrointestinal Bleeding in Warfarin and Statin Users.
Carnahan RM; Gagne JJ; Hampp C; Leonard CE; Toh S; Fuller CC; Hennessy S; Hou L; Cocoros NM; Panucci G; Woodworth T; Cosgrove A; Iyer A; Chrischilles EA
Pharmaceut Med; 2019 Feb; 33(1):29-43. PubMed ID: 31933271
[TBL] [Abstract][Full Text] [Related]
3. Building an active medical product safety surveillance system in Taiwan: Adaptation of the U.S. Sentinel System common data model structure to the National Health Insurance Research Database in Taiwan.
Huang K; Lin FJ; Ou HT; Hsu CN; Huang LY; Wang CC; Toh S
Pharmacoepidemiol Drug Saf; 2021 Jan; 30(1):97-101. PubMed ID: 33146908
[TBL] [Abstract][Full Text] [Related]
4. Sentinel Modular Program for Propensity Score-Matched Cohort Analyses: Application to Glyburide, Glipizide, and Serious Hypoglycemia.
Zhou M; Wang SV; Leonard CE; Gagne JJ; Fuller C; Hampp C; Archdeacon P; Toh S; Iyer A; Woodworth TS; Cavagnaro E; Panozzo CA; Axtman S; Carnahan RM; Chrischilles EA; Hennessy S
Epidemiology; 2017 Nov; 28(6):838-846. PubMed ID: 28682851
[TBL] [Abstract][Full Text] [Related]
5. Successful Comparison of US Food and Drug Administration Sentinel Analysis Tools to Traditional Approaches in Quantifying a Known Drug-Adverse Event Association.
Gagne JJ; Han X; Hennessy S; Leonard CE; Chrischilles EA; Carnahan RM; Wang SV; Fuller C; Iyer A; Katcoff H; Woodworth TS; Archdeacon P; Meyer TE; Schneeweiss S; Toh S
Clin Pharmacol Ther; 2016 Nov; 100(5):558-564. PubMed ID: 27416001
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the US Food and Drug Administration sentinel analysis tools in confirming previously observed drug-outcome associations: The case of clindamycin and Clostridium difficile infection.
Carnahan RM; Kuntz JL; Wang SV; Fuller C; Gagne JJ; Leonard CE; Hennessy S; Meyer T; Archdeacon P; Chen CY; Panozzo CA; Toh S; Katcoff H; Woodworth T; Iyer A; Axtman S; Chrischilles EA
Pharmacoepidemiol Drug Saf; 2018 Jul; 27(7):731-739. PubMed ID: 29532543
[TBL] [Abstract][Full Text] [Related]
7. Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system.
Toh S; Reichman ME; Houstoun M; Ross Southworth M; Ding X; Hernandez AF; Levenson M; Li L; McCloskey C; Shoaibi A; Wu E; Zornberg G; Hennessy S
Arch Intern Med; 2012 Nov; 172(20):1582-9. PubMed ID: 23147456
[TBL] [Abstract][Full Text] [Related]
8. Assessing the impact of the new ICD-10-CM coding system on pharmacoepidemiologic studies-An application to the known association between angiotensin-converting enzyme inhibitors and angioedema.
Panozzo CA; Welch EC; Woodworth TS; Huang TY; Her QL; Gagne JJ; Sun JW; Rogers C; Menzin TJ; Ehrmann M; Freitas KE; Haug NR; Toh S
Pharmacoepidemiol Drug Saf; 2018 Aug; 27(8):829-838. PubMed ID: 29947045
[TBL] [Abstract][Full Text] [Related]
9. Prospective surveillance pilot of rivaroxaban safety within the US Food and Drug Administration Sentinel System.
Chrischilles EA; Gagne JJ; Fireman B; Nelson J; Toh S; Shoaibi A; Reichman ME; Wang S; Nguyen M; Zhang R; Izem R; Goulding MR; Southworth MR; Graham DJ; Fuller C; Katcoff H; Woodworth T; Rogers C; Saliga R; Lin ND; McMahill-Walraven CN; Nair VP; Haynes K; Carnahan RM
Pharmacoepidemiol Drug Saf; 2018 Mar; 27(3):263-271. PubMed ID: 29318683
[TBL] [Abstract][Full Text] [Related]
10. The U.S. Food and Drug Administration's Mini-Sentinel program: status and direction.
Platt R; Carnahan RM; Brown JS; Chrischilles E; Curtis LH; Hennessy S; Nelson JC; Racoosin JA; Robb M; Schneeweiss S; Toh S; Weiner MG
Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():1-8. PubMed ID: 22262586
[TBL] [Abstract][Full Text] [Related]
11. A comparison of results of the US food and drug administration's mini-sentinel program with randomized clinical trials: the case of gastrointestinal tract bleeding with dabigatran.
Sipahi I; Celik S; Tozun N
JAMA Intern Med; 2014 Jan; 174(1):150-1. PubMed ID: 24247291
[No Abstract] [Full Text] [Related]
12. Angiotensin-Converting Enzyme Inhibitors Used Concomitantly with Insulin Secretagogues and the Risk of Serious Hypoglycemia.
Hee Nam Y; Brensinger CM; Bilker WB; Flory JH; Leonard CE; Hennessy S
Clin Pharmacol Ther; 2022 Jan; 111(1):218-226. PubMed ID: 34312836
[TBL] [Abstract][Full Text] [Related]
13. Multivariable confounding adjustment in distributed data networks without sharing of patient-level data.
Toh S; Reichman ME; Houstoun M; Ding X; Fireman BH; Gravel E; Levenson M; Li L; Moyneur E; Shoaibi A; Zornberg G; Hennessy S
Pharmacoepidemiol Drug Saf; 2013 Nov; 22(11):1171-7. PubMed ID: 23878013
[TBL] [Abstract][Full Text] [Related]
14. Safety assessment of niacin in the US Food and Drug Administration's mini-sentinel system.
Gagne JJ; Houstoun M; Reichman ME; Hampp C; Marshall JH; Toh S
Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):30-37. PubMed ID: 29108128
[TBL] [Abstract][Full Text] [Related]
15. Design considerations, architecture, and use of the Mini-Sentinel distributed data system.
Curtis LH; Weiner MG; Boudreau DM; Cooper WO; Daniel GW; Nair VP; Raebel MA; Beaulieu NU; Rosofsky R; Woodworth TS; Brown JS
Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():23-31. PubMed ID: 22262590
[TBL] [Abstract][Full Text] [Related]
16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
17. A Database Cohort Study to Assess the Risk of Angioedema Among Patients with Heart Failure Initiating Angiotensin-Converting Enzyme Inhibitors in the USA.
Do TP; Seetasith A; Belleli R; Schlienger RG; Corda S; Burudpakdee C; Streefkerk HJ; Behr S
Am J Cardiovasc Drugs; 2018 Jun; 18(3):205-211. PubMed ID: 29177815
[TBL] [Abstract][Full Text] [Related]
18. A COVID-19-ready public health surveillance system: The Food and Drug Administration's Sentinel System.
Cocoros NM; Fuller CC; Adimadhyam S; Ball R; Brown JS; Dal Pan GJ; Kluberg SA; Lo Re V; Maro JC; Nguyen M; Orr R; Paraoan D; Perlin J; Poland RE; Driscoll MR; Sands K; Toh S; Yih WK; Platt R;
Pharmacoepidemiol Drug Saf; 2021 Jul; 30(7):827-837. PubMed ID: 33797815
[TBL] [Abstract][Full Text] [Related]
19. Transparency, reproducibility, and replicability of pharmacoepidemiology studies in a distributed network environment.
Rai A; Maro JC; Dutcher S; Bright P; Toh S
Pharmacoepidemiol Drug Saf; 2024 Jun; 33(6):e5820. PubMed ID: 38783407
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis.
See LC; Lee HF; Chao TF; Li PR; Liu JR; Wu LS; Chang SH; Yeh YH; Kuo CT; Chan YH; Lip GYH
Cardiovasc Drugs Ther; 2021 Oct; 35(5):975-986. PubMed ID: 33211254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
